Web6 mrt. 2024 · Hingga akhir 2024, neraca CNTX tumbuh 3,69% menjadi USD41,44 juta, akibat ada peningkatan aset lancar. Baca Juga:Harga Meroket, Century Textile (CNTX) Masuk ke Radar UMA Jumlah kewajiban pembayaran (liabilitas) bertambah 5,70% menjadi USD56,09 juta. Sedangkan modal bersih defisit USD14,69 juta.
Centex (CNTX) Price Prediction CoinCodex
WebPotomac Watch Podcast; Foreign ... CNTX will report Q4 earnings on 05/10/2024 . Q4 2024 Estimate ... comprehensive quotes and volume reflect trading in all markets and are delayed at ... WebCentex’s 14-day RSI is at 40.67, indicating that CNTX is currently neutral. The RSI (Relative Strength Index) is a very popular technical indicator used to analyze prices of a variety of assets, including Centex. Most commonly, the RSI is used on a 14-day time frame. The RSI is used to gauge momentum in the market. fear of facial hair
Context Therapeutics Inc says CTIM-76 abstract accepted for ...
Web9 dec. 2024 · At quarter-end, CNTX stock had $419,152 in cash and equivalents. With this in mind, the company spent 739,598 on R&D, while spending $828,464 on general expenses. All in all, the company posted a net loss of $1.4 million in Q3. Other CNTX Stock Developments Context Therapeutics is making great strides in getting its product to the … WebCNTX Context Therapeutics Inc. Analyst Estimates MarketWatch Context Therapeutics Inc. analyst estimates, including CNTX earnings per share estimates and analyst … WebAbout CNTX Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. CEO Martin A. Lehr Employees 9 fear of failing at work